SCHEMBL6606816

SCHEMBL6606816

CCn1c(=O)c(C(=O)O)nc2cc(C)ccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.59
MAPK1 P28482 2/20 0.55
CASP1 P29466 1/20 0.55
CASP7 P55210 1/20 0.55
RAB9A P51151 2/20 0.48
MAPT P10636 4/20 0.47
KDM4E B2RXH2 4/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
HPGD P15428 2/20 0.47
THRB P10828 1/20 0.47
TLR8 Q9NR97 1/20 0.47
ALDH1A1 P00352 4/20 0.44
TP53 P04637 1/20 0.44
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
GLA P06280 1/20 0.43
CYP2D6 P10635 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9704918 0.82 MAPK1 (0.50) MAPK1CASP1CASP7MAPTKDM4E
SCHEMBL10054049 0.82 NLRP3 (0.61) NLRP3MAPK1RAB9AMAPTKDM4E
SCHEMBL9703964 0.80 MAPK1 (0.58) NLRP3MAPK1CASP1CASP7MAPT
SCHEMBL9703578 0.78 MAPK1 (0.49) MAPK1CASP1CASP7MAPTKDM4E
SCHEMBL9705722 0.78 MAPK1 (0.49) NLRP3MAPK1CASP1CASP7MAPT
SCHEMBL10989096 0.75 KDM4E (0.68) NLRP3RAB9AMAPTKDM4EKMT2A
SCHEMBL10030013 0.75 NLRP3 (1.00) NLRP3RAB9AMAPTKDM4EKMT2A
SCHEMBL30919385 0.74 BRPF1 (0.57) CASP1CASP7RAB9AMAPTKDM4E
SCHEMBL15709226 0.74 BRPF1 (0.57) CASP1CASP7RAB9AMAPTKDM4E
SCHEMBL9282229 0.74 CYP17A1 (0.44) MAPK1CASP1CASP7CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed